PL3305770T3 - Sposób wytwarzania postaci krystalicznej enzalutamidu - Google Patents
Sposób wytwarzania postaci krystalicznej enzalutamiduInfo
- Publication number
- PL3305770T3 PL3305770T3 PL16803248.0T PL16803248T PL3305770T3 PL 3305770 T3 PL3305770 T3 PL 3305770T3 PL 16803248 T PL16803248 T PL 16803248T PL 3305770 T3 PL3305770 T3 PL 3305770T3
- Authority
- PL
- Poland
- Prior art keywords
- producing
- crystal form
- enzalutamide
- enzalutamide crystal
- producing enzalutamide
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- WXCXUHSOUPDCQV-UHFFFAOYSA-N enzalutamide Chemical compound C1=C(F)C(C(=O)NC)=CC=C1N1C(C)(C)C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C1=S WXCXUHSOUPDCQV-UHFFFAOYSA-N 0.000 title 1
- 229960004671 enzalutamide Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B33/00—After-treatment of single crystals or homogeneous polycrystalline material with defined structure
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Glass Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015109805 | 2015-05-29 | ||
| PCT/JP2016/065729 WO2016194813A1 (ja) | 2015-05-29 | 2016-05-27 | エンザルタミド結晶形の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3305770T3 true PL3305770T3 (pl) | 2023-06-26 |
Family
ID=57442345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16803248.0T PL3305770T3 (pl) | 2015-05-29 | 2016-05-27 | Sposób wytwarzania postaci krystalicznej enzalutamidu |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10118899B2 (pl) |
| EP (1) | EP3305770B1 (pl) |
| JP (1) | JP6753396B2 (pl) |
| KR (1) | KR102666017B1 (pl) |
| CN (1) | CN107635969B (pl) |
| CA (1) | CA2987563C (pl) |
| ES (1) | ES2942618T3 (pl) |
| MX (1) | MX385084B (pl) |
| PL (1) | PL3305770T3 (pl) |
| PT (1) | PT3305770T (pl) |
| WO (1) | WO2016194813A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220242829A1 (en) * | 2019-06-27 | 2022-08-04 | Synthon B.V. | Process for preparation of enzalutamide |
| WO2021064123A1 (en) | 2019-10-03 | 2021-04-08 | Synthon B.V. | Pharmaceutical composition comprising enzalutamide |
| CN111217757B (zh) * | 2020-01-06 | 2021-03-19 | 武汉大学 | 一种恩杂鲁胺化合物及其药物组合物制剂 |
| CN111303042A (zh) * | 2020-03-25 | 2020-06-19 | 北京赛思源生物医药技术有限公司 | 一种恩杂鲁胺的新晶型 |
| CN114591246A (zh) * | 2022-03-25 | 2022-06-07 | 重庆华邦制药有限公司 | 一种恩扎卢胺的纯化方法 |
| CN115536591B (zh) * | 2022-09-27 | 2024-06-25 | 爱斯特(成都)生物制药股份有限公司 | 一种连续流制备恩扎卢胺的方法 |
| WO2025125565A1 (en) | 2023-12-13 | 2025-06-19 | Krka, D.D., Novo Mesto | Tablet comprising enzalutamide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ564223A (en) * | 2005-05-13 | 2011-03-31 | Univ California | Diarylhydantoin compounds for treating hormone refractory prostate cancer |
| DK2538785T3 (en) | 2010-02-24 | 2018-05-22 | Medivation Prostate Therapeutics Llc | Methods for the synthesis of diarylthiohydantoin and diarylhydantoin compounds |
| WO2011157657A1 (en) * | 2010-06-14 | 2011-12-22 | Solvay Solexis S.P.A. | Pvdf coating compositions |
| KR20150053963A (ko) * | 2012-09-11 | 2015-05-19 | 닥터 레디스 레보러터리즈 리미티드 | 엔잘루타마이드 다형태 및 그의 제조 |
| CN106543085A (zh) | 2013-10-14 | 2017-03-29 | 杭州普晒医药科技有限公司 | 恩杂鲁胺的固态形式及其制备方法和用途 |
| US9611225B2 (en) | 2014-01-27 | 2017-04-04 | Cadila Healthcare Limited | Process for preparation of androgen receptor antagonist |
| EP3166931A4 (en) | 2014-07-11 | 2018-05-09 | Shilpa Medicare Limited | An improved process for the preparation of enzalutamide |
| CN104610158A (zh) | 2015-02-03 | 2015-05-13 | 江苏慧博生物科技有限公司 | 一种恩杂鲁胺的精制方法 |
| ITUB20151204A1 (it) * | 2015-05-28 | 2016-11-28 | Olon Spa | Procedimento per la preparazione di enzalutamide |
-
2016
- 2016-05-27 WO PCT/JP2016/065729 patent/WO2016194813A1/ja not_active Ceased
- 2016-05-27 MX MX2017014958A patent/MX385084B/es unknown
- 2016-05-27 JP JP2017521901A patent/JP6753396B2/ja active Active
- 2016-05-27 ES ES16803248T patent/ES2942618T3/es active Active
- 2016-05-27 CN CN201680029674.1A patent/CN107635969B/zh active Active
- 2016-05-27 PT PT168032480T patent/PT3305770T/pt unknown
- 2016-05-27 CA CA2987563A patent/CA2987563C/en active Active
- 2016-05-27 KR KR1020177037241A patent/KR102666017B1/ko active Active
- 2016-05-27 US US15/577,007 patent/US10118899B2/en active Active
- 2016-05-27 PL PL16803248.0T patent/PL3305770T3/pl unknown
- 2016-05-27 EP EP16803248.0A patent/EP3305770B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1251218A1 (en) | 2019-01-25 |
| KR20180014015A (ko) | 2018-02-07 |
| WO2016194813A1 (ja) | 2016-12-08 |
| CN107635969A (zh) | 2018-01-26 |
| EP3305770A1 (en) | 2018-04-11 |
| JPWO2016194813A1 (ja) | 2018-06-07 |
| US10118899B2 (en) | 2018-11-06 |
| US20180148417A1 (en) | 2018-05-31 |
| PT3305770T (pt) | 2023-04-26 |
| MX2017014958A (es) | 2018-07-06 |
| MX385084B (es) | 2025-03-14 |
| CA2987563C (en) | 2024-04-09 |
| CN107635969B (zh) | 2021-08-17 |
| EP3305770A4 (en) | 2018-12-12 |
| ES2942618T3 (es) | 2023-06-05 |
| CA2987563A1 (en) | 2016-12-08 |
| KR102666017B1 (ko) | 2024-05-16 |
| EP3305770B1 (en) | 2023-03-29 |
| JP6753396B2 (ja) | 2020-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289910B1 (en) | A method for preparing allulose crystals | |
| ZA201706213B (en) | Process for producing stabilized polyacrylamides | |
| ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
| SG11201701945RA (en) | Process for making cyclohexanone | |
| SG11201701764WA (en) | Process for making cyclohexanone | |
| PL3227023T3 (pl) | Sposób wytwarzania kropel | |
| SG11201701429SA (en) | Process for making cyclohexanone | |
| PL3305770T3 (pl) | Sposób wytwarzania postaci krystalicznej enzalutamidu | |
| PL3129356T3 (pl) | Sposób wytwarzania enzalutamidu | |
| SG11201701326YA (en) | Method for producing oligosilane | |
| IL258148B (en) | Methods for producing flumetamol | |
| IL252173A0 (en) | Methods for the production of methyl dichlorophosphane | |
| IL253877B (en) | Process for the preparation of 3-chloro-2-vinylphenylsulfonates | |
| PL3182981T3 (pl) | Sposób wytwarzania izomaltooligosacharydów | |
| ZA201801650B (en) | Process for producing novel 4-benzoazonine derivatives | |
| SI3356541T1 (sl) | Postopek za proizvodnjo L-metionina | |
| HUE049907T2 (hu) | Eljárás L-metionin elõállítására | |
| PL3299394T3 (pl) | Sposób wytwarzania zmodyfikowanych ksylopolisacharydów | |
| SG11201701480VA (en) | Process for producing silicon single crystal | |
| PL3006400T3 (pl) | Sposób wytwarzania amoniaku | |
| IL255093A0 (en) | A method for the production of levoglucosenon | |
| IL249283A0 (en) | Process for the preparation of 3-chloro-2-vinylphenol | |
| KZ31594B (ru) | Способ производствашоколада | |
| PL3105029T3 (pl) | Sposób wytwarzania części | |
| ZA201803631B (en) | Improved process for making crotonylaminopyridines |